当前位置:首页 - 行情中心 - 普昂医疗(920069) - 财务分析 - 现金流量表

普昂医疗

(920069)

  

流通市值:5.58亿  总市值:16.89亿
流通股本:1748.95万   总股本:5291.98万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金354,323,166.72226,686,914.65111,776,009.34394,459,984.84
  收到的税费返还9,985,3694,981,588.392,387,971.819,683,144.47
  收到其他与经营活动有关的现金5,005,244.983,060,925.012,599,663.4812,364,324.32
  经营活动现金流入小计369,313,780.7234,729,428.05116,763,644.63416,507,453.63
  购买商品、接受劳务支付的现金133,740,368.4381,072,915.5743,850,138.19160,390,616.21
  支付给职工以及为职工支付的现金77,092,136.9352,064,317.0828,169,552.9380,234,448.97
  支付的各项税费17,275,473.8812,646,520.838,034,865.9219,551,216.26
  支付其他与经营活动有关的现金41,289,892.6824,797,969.599,292,902.1741,059,655.89
  经营活动现金流出小计269,397,871.92170,581,723.0789,347,459.21301,235,937.33
  经营活动产生的现金流量净额99,915,908.7864,147,704.9827,416,185.42115,271,516.3
二、投资活动产生的现金流量:
  收回投资收到的现金164,000,00065,000,000--
  取得投资收益收到的现金146,964.5340,136.97--
  处置固定资产、无形资产和其他长期资产收回的现金净额597,646.28182,175.96-472,300
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计164,744,610.8165,222,312.93-472,300
  购建固定资产、无形资产和其他长期资产支付的现金90,160,349.6747,891,961.3320,804,235.1963,238,809.28
  投资支付的现金224,000,000133,000,000--
  投资活动现金流出小计314,160,349.67180,891,961.3320,804,235.1963,238,809.28
  投资活动产生的现金流量净额-149,415,738.86-115,669,648.4-20,804,235.19-62,766,509.28
三、筹资活动产生的现金流量:
  吸收投资收到的现金194,639,672.04194,511,864194,511,864-
  取得借款收到的现金---15,000,000
  筹资活动现金流入小计194,639,672.04194,511,864194,511,86415,000,000
  偿还债务支付的现金19,098,734.1819,098,734.186,000,00088,255,409.12
  分配股利、利润或偿付利息支付的现金27,079,857.9127,079,857.9153,804.73560,395.16
  支付其他与筹资活动有关的现金25,251,564.4125,251,564.4116,852,830.193,562,264.16
  筹资活动现金流出小计71,430,156.571,430,156.522,906,634.9292,378,068.44
  筹资活动产生的现金流量净额123,209,515.54123,081,707.5171,605,229.08-77,378,068.44
四、汇率变动对现金及现金等价物的影响-4,633,670.75-3,357,531.11-1,538,333.96653,228.1
五、现金及现金等价物净增加额69,076,014.7168,202,232.97176,678,845.35-24,219,833.32
  加:期初现金及现金等价物余额33,913,805.3633,913,805.3633,913,805.3658,133,638.68
  期末现金及现金等价物余额102,989,820.07102,116,038.33210,592,650.7133,913,805.36
补充资料:
  净利润-53,139,178.38-89,775,785.62
  资产减值准备-995,988.48-2,419,735.14
  固定资产和投资性房地产折旧-20,471,892.26-37,972,454.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-20,471,892.26-37,972,454.82
  无形资产摊销-762,237.8-1,491,423.53
  长期待摊费用摊销-17,510.28-12,968.68
  处置固定资产、无形资产和其他长期资产的损失-41,040.72-27,650.17
  固定资产报废损失-940.17-24,125.07
  财务费用-3,451,188.81--147,182.42
  投资损失--40,136.97--
  递延所得税-82,536.48-728,600.66
  其中:递延所得税资产减少-193,983.34-923,860.51
    递延所得税负债增加--111,446.86--195,259.85
  存货的减少--12,987,572.05--14,746,864.3
  经营性应收项目的减少--8,166,994.63--15,676,864.11
  经营性应付项目的增加-5,094,194.64-11,039,489.77
  其他-1,014,810.97-1,454,873.88
  现金的期末余额-102,116,038.33-33,913,805.36
  减:现金的期初余额-33,913,805.36-58,133,638.68
  现金及现金等价物的净增加额-68,202,232.97--24,219,833.32
公告日期2026-10-282026-08-262026-04-232026-02-05
审计意见(境内)标准无保留意见
TOP↑